Drugs that Treat Anemia May Be Harmful to Kidney Patients

Posted on February 15, 2016 by Disability Help Group

A new study indicates that drugs used to treat anemia may be harmful to kidney patients. Individuals who suffer from chronic kidney disease may be unable to work for a period of time while they undergo treatment and recovery. Long-term disability benefits can help cover lost wages during this time.

Individuals with chronic kidney disease and type 2 diabetes sometimes take anemia drugs which should cause the levels of hemoglobin cells in their blood to increase. However, a new study indicates that if the hemoglobin levels don’t rise, it can significantly increase the risk for heart problems, and even death.

Some types of anemia drugs such as Epogen, Procrit and Aranesp, may increase the risk of a cardiovascular event by as much as 31% and death by 41%. This demonstrates that individuals with chronic kidney disease may need to be more cautious about using drugs that treat anemia.

Researchers have not been able to determine the cause of this increased risk. Patients with chronic kidney disease are encouraged to discuss with their doctors the potential risk of taking an anemia drug.

If you have been diagnosed with chronic kidney disease, type 2 diabetes or any other severe mental or physical disability you may qualify for long-term disability benefits. You should contact a long-term disability representative who can help determine eligibility.

The long-term disability representatives at Disability Help Group have experience with cross examining medical and vocational experts and take time when speaking with you about your case. Call us today at 1-(800)-800-3332 for a FREE consultation.